NCT03637855 is a clinical trial in Healthy, sponsored by University of Hawaii.

Who is sponsoring NCT03637855?

NCT03637855 is sponsored by University of Hawaii.

Is NCT03637855 still recruiting?

NCT03637855 is currently completed. Last updated 9 May 2022.

Last reviewed 2022-05-09 · How we verify

NCT03637855

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shape Up! Adults Study

Completed Last updated 9 May 2022

What this trial tests

trial in Healthy in 696 participants. Completed in 31 December 2021.

Timeline

1 October 2016

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	University of Hawaii
Status	Completed
Study type	OBSERVATIONAL
Enrollment	696
Start date	1 October 2016
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across United States

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Hawaii

Who can join

Adults 18 to 80, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Identify the unique associations of body shape to body composition indices in a population that represents the variance of sex, age, BMI, and ethnicity found in the US population. Describe the precision and accuracy of 3DO scans to monitor change in body composition and metabolic health interventions. Estimate the level of association of 3DO to common health indicators including metabolic risk factors (glucose, triglycerides, HDL-cholesterol, blood pressure, VAT, WC and strength) by gender, race, age, and BMI. Investigate holistic, high-resolution descriptors of 3D body shape as direct predictors of body composition and metabolic risk using statistical shape models and Latent Class Analysis.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial.
Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, et al · · 2020 · cited 375× · PMID 32986097 · DOI 10.1001/jamainternmed.2020.4153
Detailed 3-dimensional body shape features predict body composition, blood metabolites, and functional strength: the Shape Up! studies.
Ng BK, Sommer MJ, Wong MC, Pagano I, et al · · 2019 · cited 72× · PMID 31553429 · DOI 10.1093/ajcn/nqz218
Improved strength prediction combining clinically available measures of skeletal muscle mass and quality.
Bourgeois B, Fan B, Johannsen N, Gonzalez MC, et al · · 2019 · cited 53× · PMID 30371008 · DOI 10.1002/jcsm.12353
Assessment of clinical measures of total and regional body composition from a commercial 3-dimensional optical body scanner.
Bennett JP, Liu YE, Quon BK, Kelly NN, et al · · 2022 · cited 37× · PMID 34915272 · DOI 10.1016/j.clnu.2021.11.031
Novel body fat estimation using machine learning and 3-dimensional optical imaging.
Harty PS, Sieglinger B, Heymsfield SB, Shepherd JA, et al · · 2020 · cited 36× · PMID 32203233 · DOI 10.1038/s41430-020-0603-x
Anthropometric evaluation of a 3D scanning mobile application.
Smith B, McCarthy C, Dechenaud ME, Wong MC, et al · · 2022 · cited 31× · PMID 35491718 · DOI 10.1002/oby.23434
Predicting 3D body shape and body composition from conventional 2D photography.
Tian IY, Ng BK, Wong MC, Kennedy S, et al · · 2020 · cited 27× · PMID 32978970 · DOI 10.1002/mp.14492
Smartphone prediction of skeletal muscle mass: model development and validation in adults.
McCarthy C, Tinsley GM, Yang S, Irving BA, et al · · 2023 · cited 25× · PMID 36822238 · DOI 10.1016/j.ajcnut.2023.02.003

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Hawaii trials

Trials by the same sponsor.

NCT06964633 — The Ku Ola Project: Enhancing Health Promotion Among Native Hawaiian Men. · NA · not yet recruiting
NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
NCT07075575 — Quit-Smoking Study for Native Hawaiians · NA · not yet recruiting
NCT07075120 — Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer · Phase 1 · not yet recruiting
NCT06978790 — Generative Artificial Intelligence Nurse Staffing Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03637855 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Hawaii
Last refreshed: 9 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03637855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing